News | July 08, 2010

TCT Surgeons Course Highlights Role of Hybrid Suites

The hybrid suite at the Texas Heart Hospital Baylor Plano, Texas.

July 8, 2010 – The annual Transcatheter Cardiovascular Therapeutics (TCT) event has traditionally been a symposium for interventional cardiologists. However, as an increasing number of hybrid intervention/minimally invasive surgical procedures bring surgeons into the arena of cath lab techniques, TCT started a course for surgeons who specialize in hybrid procedures. Now in its fourth year, the course will run during TCT, Sept. 21-25, 2010, in Washington, D.C.

“This meeting will drive forward the growing collaboration among interventional cardiologists and cardiac surgeons in the treatment of patients with structural and coronary artery disease,” said Mathew Williams, M.D., course director, and surgical director, Cardiovascular Transcatheter Therapies at New York-Presbyterian Hospital/Columbia University Medical Center. “The surgeon brings tremendous knowledge, a valuable skill set and a unique perspective to the interventional environment and the cross-trained surgeon is positioned ideally to make the most informed and unbiased treatment decision for patients with coronary and endovascular disease.”

One of the course highlights is an overview of hybrid coronary therapy, which involves a combination of traditional surgery along with the placement of coronary stents in patients with coronary artery disease. The chosen therapy, whether it is angioplasty, surgery or a combination of the two, should be determined specifically for an individual patient, Williams said.

The course also includes sessions on valvular heart disease, minimally invasive surgery, new surgical technologies, abdominal aortic endografting, aortic aneurismal disease overview and thoracic aortic endografting.

For more information:

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Overlay Init